Evaluation of mortality rate among ICU patients in university hospitals of Tehra
DOI:
https://doi.org/10.61841/87r7fq31Keywords:
Deaths, Factor, Intensive Care Unit, Hospitalized PatientsAbstract
Objective: One of the challenging issues in the intensive care unit, in addition to controlling mortality, is the identification of effective factors in this area. Previous studies have found many causes, including diagnosis of disease, age, chronic health status and physiological indicators, in terms of mortality. However, there are disagreements about the causes of death. In this study, we have tried to investigate the causes and factors affecting mortality in Tehran hospitals.
Data Sources: In this cross-sectional and retrospective study, mortality rate and its risk factors were evaluated in intensive care units in university hospitals in Tehran.
Study Selection: This study was conducted in 2011-2015 years in 12857 patients. In this study age, sex, duration of hospitalization in ICU, cause of hospitalization, underlying disease, date of discharge or death, cause of death, type of ICU and APACHE score.
Data Extraction: The results of the study showed that the highest mortality rate was in men (p = 0.001). Data Synthesisthere was a direct correlation between mortality rates and segments of closed ICU, duration of admission, cause of hospitalization, aphasia score of patients, while there was no significant relationship between age and mortality (P = 0.8)
Conclusions: The results of this study were consistent with many previous studies, but the mortality rate with the high level of the statistical society has been less frequent than previous studies. However, the need for study in different populations is needed to achieve better results.
Downloads
References
1. Haidri F. R., Rizvi N., Motiani B. Role of Apache score in predicting mortality in chest ICU. J Pak Med Assoc. June 2011; 6; 61: 589–592.
2. Siegel T., Adamski J., Nowakowski P., et al. Prospective assessment of the standardized mortality ratio (SMR) as a measure of quality of care in an intensive care unit — a single-centre study. Anaesthesiology Intensive Therapy 2015; 47(4): 328–332.
3. Capuzzo M., Volta C. A., Tassinati T., et al. Hospital mortality of adults admitted to Intensive Care Units in hospitals with and without Intermediate Care Units: a multicentre European cohort study. Critical Care. 2014 Oct; 18(5): 551.
4. Senturk E., Senturk Z., Sen S., et al. Mortality and associated factors in a thoracic surgery ICU. J Bras Pneumol. 2011; 37(3): 367–374.
5. Pirracchio R., Petersen M. L., Carone M., et al. Mortality prediction in the ICU: can we do better? Results from the Super ICU Learner Algorithm (SICULA) project, a population-based study. Lancet Respir Med. 2015 Jan; 3(1): 42–52.
6. Khwannimit B., Geater A. A comparison of APACHE II and SAPS II scoring systems in predicting hospital mortality in Thai adult intensive care units. J Med Assoc Thai. 2007 Apr; 90(4): 643–652.
7. Matic I., Titlic M., Dikanovic M., et al. Effects of APACHE II score on mechanical ventilation; prediction and outcome. Acta Anaesthesiol Belg. 2007; 58(3): 177–183.
8. Kashefi P., Eghei H., Khalifesoltani M. Epidemiologic and demographic aspects and causes of hospitalization and mortality in patients admitted to Intensive Care Units of Alzahra Hospital, Isfahan, Iran, during 2011–2015. J Isfahan Med Sch 2017; 35(428): 476–481.
9. Bikenbach J., Fries M., Rex S., et al. Outcome and mortality risk factors in long-term treated ICU patients: a retrospective analysis. Minerva Anestesiologica. April 2011; 77(4): 427–438.
10. Fuchs L., Novack V., McLennan S., et al. Trends in severity of illness on ICU admission and mortality among the elderly. PLoS ONE. 2014; 9(4): e93234.
11. Knaus W. A., Zimmerman J. E., Wagner D. P., et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981 Aug; 9(8): 591–597.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
